Strategic partnership and planned acquisition position Fifty1 Labs to dominate AI-driven drug repurposing and wellness ...

Forever chemicals —also known as per- and polyfluoroalkyl substances, or PFAs, that don’t break down, but linger in the ...

Universities that rely on advanced degrees as a lucrative — and in some cases, essential — source of revenue are preparing to ...

While tingling hands is a big sign of B12 deficiency, it is not the only deficiency linked to the sensation. Vitamin D, B6, ...

More than half a dozen medical professionals detailed the problems with the cancer claims made by a Monroe County woman ...

Dr. Tweezer-Zaks Transitions from the Company’s Board of Directors to Lead Medical Strategy Following Positive Phase 3 ...

Rates of the world's deadliest cancer appear to be low in sub-Saharan Africa. But that statistic is masking the scope of the ...

Panelists discuss how upcoming ASCO presentations will focus on long-term CAR T-cell therapy outcomes showing potential cure ...

In cholera-ravaged refugee camps of western Sudan, fear spreads as swiftly as the deadly bacteria. Before water can even be ...

When Gen. Kuol Manyang Juuk stated that the detention of Dr. Riek Machar Teny is “a criminal matter, not political,” he was ...

John C. Reed, Executive Vice President, Innovative Medicine and R&D of Johnson & Johnson( JNJ 0.35%), executed an open market sale of 19,137 shares as disclosed in a Form 4 filed July 18, 2025.

Mayo Clinic partnered with Nvidia to launch an AI computing platform designed to support the development of foundation models used in areas like digital pathology, drug discovery and precision ...